Training in Bariatric and Metabolic Endoscopic Therapies

키워드

참고문헌 (35)

1. "Obesity and overweight" (2018)[URL]
2. Jensen MD, "2013 AHA", ACC, American Heart Association Task Force on Practice Guidelines and The Obesity Society, pp.J Am Coll Cardiol, 2014[DOI]
3. Look AHEAD Research Group, "Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study", Obesity (Silver Spring), 22, pp.5~13 (2014)[DOI]
4. Igel LI, "Practical use of pharmacotherapy for obesity", Gastroenterology, 152, pp.1765~1779 (2017)[DOI]
5. Corcelles R, "Total weight loss as the out-come measure of choice after Roux-en-Y gastric bypass", Obes Surg, 26, pp.1794~1798 (2016)[DOI]
6. Ponce J, "American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014", Surg Obes Relat Dis, 11, pp.1199~1200 (2015)[DOI]
7. Abu Dayyeh BK, "A randomized, multi-center study to evaluate the safety and effectiveness of an intragastric balloon as an adjunct to a behavioral modification program, in comparison with a behavioral modification program alone in the weight management of obese subjects", Gastrointest Endosc, 81(5 Suppl), pp.AB147~ (2015)
8. Ponce J, "The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity", Surg Obes Relat Dis, 11, pp.874~881 (2015)[DOI]
9. Sullivan S, "The obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6- month randomized sham controlled trial", Gastroenterology, 150(4 Suppl), pp.S1267~ (2016)
10. "Summary of safety and effectiveness data (SSED): ORBERA™ intragastric balloon system" (2015)[URL]
11. "Summary of safety and effectiveness data (SSED): obalon balloon system" (2016)[URL]
12. "Summary of safety and effectiveness data (SSED): ReShape™ integrated dual balloon system" (2015)[URL]
13. Jirapinyo P, "Evaluation of an endoscopic suturing device for transoral outlet reduction in patients with weight regain following Roux-en-Y gastric bypass", Endoscopy, 45, pp.532~536 (2013)[DOI]
14. Sharaiha RZ, "Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population", Endoscopy, 47, pp.164~166 (2015)
15. Kumar N, "Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up", Gastrointest Endosc, 83, pp.776~779 (2016)[DOI]
16. Lopez-Nava G, "Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success", Endosc Int Open, 4, pp.E222~E227 (2016)[DOI]
17. Lopez-Nava G, "Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up", Obes Surg, 27, pp.2649~2655 (2017)[DOI]
18. Miller K, "MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy", Obes Surg, 27, pp.310~322 (2017)[DOI]
19. Lopez-Nava G, "The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes", Surg Obes Relat Dis, 11, pp.861~865 (2015)[DOI]
20. Thompson CC, "Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial", Am J Gastroenterol, 112, pp.447~457 (2017)[DOI]
21. Jirapinyo P, "Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action", Clin Gastroenterol Hepatol, 15, pp.619~630 (2017)[DOI]
22. Foxx-Orenstein AE, "Gastrointestinal symptoms and diseases related to obesity: an overview", Gastroenterol Clin North Am, 39, pp.23~37 (2010)[DOI]
23. Camilleri M, "Gastrointestinal complications of obesity", Gastroenterology, 152, pp.1656~1670 (2017)[DOI]
24. Jirapinyo P, "Patients with Roux-en-Y gastric bypass require increased sedation during upper endoscopy", Clin Gastroenterol Hepatol, 13, pp.1432~1436 (2015)[DOI]
25. ASGE, "ASMBS Task Force on Endoscopic Bariatric Therapy", A pathway to endoscopic bariatric therapies, 2011, pp.7, 672~682
26. Sullivan S, "Endoscopic bariatric and metabolic therapies: new and emerging technologies", Gastroenterology, 152, pp.1791~1801 (2017)[DOI]
27. Kushner RF, "The American board of obesity medicine: five-year report", Obesity (Silver Spring), 25, pp.982~984 (2017)[DOI]
28. Patel LY, "Outcomes following 50 consecutive endoscopic gastrojejunal revisions for weight gain following Roux-en-Y gastric bypass: a comparison of endoscopic suturing techniques for stoma reduction", Surg Endosc, 31, pp.2667~2677 (2017)[DOI]
29. Jirapinyo P, "Purse-string transoral outlet reduction (TORe) is effective at inducing weight loss and improvement in metabolic comorbidities after Roux-en-Y gastric bypass", Endoscopy, 50, pp.371~377 (2018)[DOI]
30. Schulman AR, "Transoral outlet reduction: a comparison of purse-string with interrupted stitch technique", Gastrointest Endosc, 87, pp.1222~1228 (2018)[DOI]
31. Jirapinyo P, "Endoscopic suturing: indications, procedural complexity and learning curve", Gastrointest Endosc, 83(5 Suppl), pp.AB494~AB495 (2016)
32. Skinner MJ, "Development and initial validation of a fully synthetic and reusable endoscopic suturing simulator", Gastrointest Endosc, 85(5 Suppl), pp.AB502~AB503 (2017)
33. Acosta A, "White paper AGA: POWER - practice guide on obesity and weight management, education, and resources", Clin Gastroenterol Hepatol, 15, pp.631~649 (2017)[DOI]
34. ASGE Bariatric Endoscopy Task Force, "ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies", Gastrointest Endosc, 82, pp.425~438 (2015)[DOI]
35. Berthoud HR, "Advances in obesity: causes, consequences, and therapy", Gastroenterology, 152, pp.1635~1637 (2017)[DOI]

관련 논문AI추천